| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.CIR.91.5.1450 |
| P698 | PubMed publication ID | 7867186 |
| P2093 | author name string | J Díez | |
| C Laviades | |||
| I Monreal | |||
| M J Gil | |||
| G Mayor | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | serum concentration | Q126107668 |
| P304 | page(s) | 1450-1456 | |
| P577 | publication date | 1995-03-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations | |
| P478 | volume | 91 |
| Q33718262 | Angiotensin II and connective tissue: homeostasis and reciprocal regulation |
| Q44417535 | Angiotensin-converting enzyme-gene polymorphism is associated with collagen I synthesis and QT dispersion in essential hypertension |
| Q82793514 | Associations between collagen synthesis and degradation and aortic function in arterial hypertension |
| Q41852121 | Atrophic cardiomyocyte signaling in hypertensive heart disease |
| Q40300916 | Biochemical evidence of myocardial fibrosis in veteran endurance athletes |
| Q38603770 | Cardiac biomarkers in children with congenital heart disease |
| Q35777180 | Cardiac microinjury measured by troponin T predicts collagen metabolism in adults aged >=65 years with heart failure. |
| Q36699619 | Cellular mechanisms of tissue fibrosis. 2. Contributory pathways leading to myocardial fibrosis: moving beyond collagen expression |
| Q64094041 | Circulating Aminoterminal Propeptide of Type III Procollagen as a Biomarker of Cardiovascular Events in Patients Undergoing Hemodialysis |
| Q41825944 | Circulating Procollagen Type III N-Terminal Peptide and Mortality Risk in African Americans With Heart Failure |
| Q34533063 | Circulating annexin A5 levels after atrial switch for transposition of the great arteries: relationship with ventricular deformation and geometry |
| Q38152289 | Circulating biomarkers in patients with heart failure and preserved ejection fraction |
| Q95260893 | Circulating biomarkers in the early detection of hypertensive heart disease: usefulness in the developing world |
| Q35207721 | Clinical and echocardiographic correlates of plasma procollagen type III amino-terminal peptide levels in the community |
| Q83104355 | Collagen type-I degradation is related to arterial stiffness in hypertensive and normotensive subjects |
| Q50452526 | Computational model of collagen turnover in carotid arteries during hypertension. |
| Q41611764 | Diastolic dysfunction in heart failure |
| Q47668936 | Dynamic assessment of myocardial involvement in patients with end-stage renal disease by ultrasonic tissue characterization and serum markers of collagen metabolism. |
| Q79777448 | Effect of dual blockade of renin-angiotensin system on TGFbeta1 and left ventricular structure and function in hypertensive patients |
| Q46529669 | Effect of valsartan and ramipril on atrial fibrillation recurrence and P-wave dispersion in hypertensive patients with recurrent symptomatic lone atrial fibrillation |
| Q37464914 | Extracellular matrix fibrotic markers in heart failure |
| Q45222028 | Markers of collagen synthesis is related to blood pressure and vascular hypertrophy: a LIFE substudy |
| Q45077001 | Mathematical modeling of collagen turnover in biological tissue |
| Q35843045 | Measuring serum aminoterminal type III procollagen peptide, 7S domain of type IV collagen, and cardiac troponin T in patients with idiopathic dilated cardiomyopathy and secondary cardiomyopathy. |
| Q33632033 | Membrane-associated matrix proteolysis and heart failure. |
| Q34477882 | Modest elevation in BNP in asymptomatic hypertensive patients reflects sub-clinical cardiac remodeling, inflammation and extracellular matrix changes. |
| Q92043864 | Modulation of PTEN by hexarelin attenuates coronary artery ligation-induced heart failure in rats |
| Q46664447 | Myocardial collagen turnover in normotensive obese patients: relation to insulin resistance |
| Q35535837 | Myocardial remodeling with aortic stenosis and after aortic valve replacement: mechanisms and future prognostic implications. |
| Q37662291 | Novel fibro-inflammation markers in assessing left atrial remodeling in non-valvular atrial fibrillation. |
| Q55434646 | Predictive Value of Collagen Biomarkers for Heart Failure With and Without Preserved Ejection Fraction: MESA (Multi-Ethnic Study of Atherosclerosis). |
| Q37310302 | Procollagen type III N-terminal peptide (P3NP) and lean mass: a cross-sectional study |
| Q43101162 | Protease with collagenolytic activity produced by Bacillus sp. DPUA 1728 from Amazonian soil |
| Q37363507 | Rationale and design of a randomized trial on the impact of aldosterone antagonism on cardiac structure and function in diabetic cardiomyopathy. |
| Q34222299 | Relations of biomarkers of extracellular matrix remodeling to incident cardiovascular events and mortality |
| Q37312630 | Relations of matrix remodeling biomarkers to blood pressure progression and incidence of hypertension in the community |
| Q38489694 | Relationship between serum biochemical markers of myocardial fibrosis and diastolic function at rest and with exercise in hypertrophic cardiomyopathy |
| Q36473364 | Screening for ventricular remodeling |
| Q80524465 | Serum carboxyl-terminal propeptide of procollagen type I in exercise-induced left ventricular hypertrophy |
| Q55154166 | Structural alterations in rat myocardium induced by chronic l-arginine and l-NAME supplementation. |
| Q99587532 | Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle? |
| Q40948143 | The evolving paradigm of hypertension. |
| Q81791292 | The relationship between pulse wave velocity and indexes of collagen synthesis in hypertensive patients, according to the level of systolic blood pressure |
| Q34338635 | Time course of early changes in plasma markers of collagen turnover following percutaneous transluminal coronary angioplasty |
| Q46430722 | Time course of serum collagen types I and III metabolism products after reperfused acute myocardial infarction in patients with and without systemic hypertension |
| Q40380038 | Toward the biochemical assessment of myocardial fibrosis in hypertensive patients |
| Q36366148 | Vulnerable myocardial interstitium in patients with isolated left ventricular hypertrophy and sudden cardiac death: a postmortem histological evaluation |
| Q33640255 | Why does spironolactone improve mortality over and above an ACE inhibitor in chronic heart failure? |
Search more.